Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Rheumatrex

Rheumatrex
In stock
2.5mg · 10mg
from A$47.49
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$56.99A$47.49
A$1.58 per tablet

In brief

  • In some pharmacies it may be possible to buy rheumatrex without a receipt, but officially methotrexate (Rheumatrex) is a prescription-only medicine and should be used only under medical supervision.
  • Rheumatrex (methotrexate) is used to treat rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriasis and certain cancers; it is an antimetabolite and folic acid analogue that inhibits dihydrofolate reductase, reducing DNA synthesis and producing immunosuppressive and anti‑inflammatory effects.
  • Usual doses vary by condition — for rheumatoid arthritis 7.5–15 mg once weekly, for severe psoriasis 10–25 mg once weekly, and in juvenile idiopathic arthritis about 10–15 mg/m² once weekly; oncology dosing is specialist and highly variable.
  • Forms of administration include oral tablets and oral solution, subcutaneous injection (pre-filled syringes/auto‑injectors), and intravenous/intramuscular vials for injection.
  • Clinical improvement for inflammatory conditions typically begins within about 3–6 weeks, with full benefit often seen by 12 weeks.
  • Because methotrexate is usually given weekly, the pharmacologic effect is sustained over the week after each dose; ongoing maintenance dosing is common for chronic conditions.
  • Avoid alcohol while taking methotrexate because alcohol increases the risk of liver toxicity and other adverse effects; pregnancy must be avoided due to severe teratogenic risk.
  • The most common side effects include nausea, mouth sores (stomatitis), mild cytopenias and elevated liver enzymes; folic acid supplementation is commonly recommended to reduce some side effects.
  • Would you like to try rheumatrex without a prescription?

Basic Rheumatrex Information

  • INN (International Nonproprietary Name): Methotrexate.
  • Brand Names Available In Australia: Rheumatrex; Trexall; Xatmep; Jylamvo; Otrexup; Rasuvo; Metoject; Methotrexat; Emthexate; Methotrex (availability varies by supplier; specific Australian brand registration not specified).
  • ATC Code: L01BA01.
  • Forms & Dosages: Tablets 2.5 mg, 5 mg, 7.5 mg, 10 mg; oral solution 2 mg/ml (e.g., Jylamvo in some markets); prefilled syringes/auto‑injectors 7.5–30 mg; injection vials (e.g., 25 mg/ml, 50 mg/2 ml, 500 mg/20 ml).
  • Manufacturers In Australia: not specified.
  • Registration Status In Australia: not specified.
  • OTC / Rx Classification: Prescription‑only (Rx) globally.

Critical Warnings & Restrictions

This medicine carries serious risks that must be managed before and during treatment.

Methotrexate is absolutely contraindicated in pregnancy and breastfeeding because of teratogenic and embryo‑fetal toxicity.

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Do not start methotrexate in anyone who is pregnant or breastfeeding without specialist advice and documented negative pregnancy testing.

Older adults should start on lower doses and have closer monitoring because renal function often affects methotrexate clearance.

Severe hepatic or renal impairment, active alcoholism, chronic liver disease and bone marrow suppression are contraindications.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Methotrexate can cause fatigue, dizziness and visual disturbance in some people.

Patients must not drive or operate heavy machinery until they know how methotrexate affects them.

Employers and health‑and‑safety officers should treat methotrexate as a drug that may impair fitness for certain tasks under normal workplace duty‑of‑care provisions.

Q&A — “Can I Drive After Taking It In Australia?”

Short answer: avoid driving or operating heavy machinery if you feel drowsy, dizzy or have visual changes after taking methotrexate.

Report any new side effects to your prescriber and follow local workplace safety guidance.

  • Absolute contraindications: pregnancy, breastfeeding, severe hepatic or renal impairment, alcoholism, bone marrow hypoplasia, hypersensitivity.
  • Baseline and ongoing monitoring: CBC, liver function tests and creatinine every 1–3 months during long‑term therapy.
  • Pre‑treatment screening checklist: negative pregnancy test; reliable contraception advice; baseline CBC, LFTs and creatinine; hepatitis B and C screening; vaccination status review.

Refer to Therapeutic Goods Administration safety communications and call Poisons Information on 13 11 26 for urgent toxicity advice.

Usage Basics

INN, Brand Names Available In Australia

INN: Methotrexate.

Well‑known international brands include Rheumatrex, Trexall, Xatmep, Jylamvo, Otrexup, Rasuvo and Metoject.

Availability of specific brands and pack sizes in Australia depends on local registration and supply chains.

Legal Classification (TGA‑Approved, PBS‑Listed)

Methotrexate is prescription‑only and requires TGA approval for listed products to be supplied in Australia.

Low‑dose methotrexate for rheumatoid arthritis and psoriasis is commonly subsidised on the PBS for approved indications subject to Authority rules.

Formulation Australian Availability
Tablets (2.5 mg, 5 mg, 7.5 mg, 10 mg) Commonly available through pharmacies (brand and pack size depend on supplier).
Oral Solution (2 mg/ml) Available internationally (Jylamvo); local availability varies.
Prefilled Injectors / Syringes (7.5–30 mg) Available from some manufacturers and importers; supply varies.
Vials for Injection Used in hospital and specialist settings; strengths vary.
INN
International Nonproprietary Name for the active substance (Methotrexate).
ATC
Therapeutic classification L01BA01 for antimetabolite folic acid analogues.
Dose Pack
Pre‑measured tablets or blister packs intended to help with weekly dosing adherence.

Always check the TGA ARTG and the PBS Schedule for current registration and subsidy details.

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Typical starting dose for rheumatoid arthritis is 7.5–15 mg once weekly, taken orally or subcutaneously.

For severe psoriasis, typical dosing ranges from 10–25 mg once weekly depending on disease severity and specialist direction.

Never take low‑dose methotrexate daily unless under oncology protocols set by a specialist.

Adjustments For Comorbidities

Children use body surface area dosing (around 10–15 mg/m² once weekly for juvenile idiopathic arthritis).

Elderly patients often start lower and require close renal monitoring because clearance falls with age.

Severe hepatic or renal impairment is a contraindication; mild to moderate impairment requires dose reduction and specialist advice.

Folic acid supplementation is routinely prescribed to reduce gastrointestinal and haematologic side effects.

Q&A — “What If I Miss A Dose?”

If you miss your weekly dose, take it the same day if you remember and it is still that day.

If more than a day has passed, skip the missed dose and take your next scheduled weekly dose.

Do not double the dose to catch up and contact your prescriber or Poisons Information on 13 11 26 if unsure.

  • Start dose: document indication and weekly schedule.
  • Baseline labs: CBC, LFTs, creatinine, hepatitis screen.
  • Folic acid: typically prescribed (dose varies by prescriber).
  • Monitoring intervals: CBC, LFTs, creatinine every 1–3 months.

Interaction Chart

Food And Drinks (Alcohol, Coffee, Australian Diet Context)

Alcohol increases the risk of hepatotoxicity while taking methotrexate and should be minimised or avoided.

Coffee intake does not have a direct interaction with methotrexate in standard resources, but discuss any large changes in diet with your prescriber.

Disclose native bush foods or supplements to your pharmacist, especially if they are claimed to be hepatoprotective or hepatotoxic.

Common Drug Conflicts

Interacting Agent Mechanism Clinical Risk Action
NSAIDs (ibuprofen, naproxen) Reduce renal excretion of methotrexate. Increased toxicity risk (renal, haematologic). Avoid or monitor closely.
Trimethoprim / Sulfonamides Potentiate marrow suppression. Severe cytopenias. Avoid or seek specialist advice.
Some Antibiotics (high‑dose penicillins, ceftriaxone) Alter renal clearance or displace protein binding. Elevated methotrexate levels. Monitor or adjust dose.
Proton Pump Inhibitors May reduce clearance. Increased toxicity risk. Review necessity; monitor.
Other DMARDs / Biologics Combined immunosuppression. Infection risk, compounded toxicity. Specialist supervision required.
Live Vaccines Impaired immune response. Risk of vaccine‑related infection. Avoid while immunosuppressed; check vaccination timing.
  • OTC and household items to check: NSAIDs, trimethoprim, high‑dose vitamin supplements, herbal liver products.
  • Bring a full medicines list to every pharmacy visit and tell the pharmacist about herbal or complementary therapies.

User Reports & Trends

Patients commonly say methotrexate controls joint pain and skin disease effectively within weeks.

Frequent complaints in reviews and consultations are nausea, mouth ulcers, hair thinning and fatigue.

Many patients note folic acid helps reduce gastrointestinal side effects and mouth sores.

Rural patients report slower access to specialist training for injectable devices and longer wait times for rheumatology follow‑up.

Telehealth and e‑prescriptions have improved access for remote patients in recent years.

  • Common reported side effects: nausea, stomatitis, fatigue, mild hair loss, transient liver enzyme rises.
  • Adherence barriers: weekly schedule confusion, concern about teratogenicity, cost despite PBS subsidies.
  • Positive outcomes: reduced flares, improved mobility, lower steroid use.
Source Typical Satisfaction
Online Reviews Generally positive for efficacy; side effects noted.
Pharmacist Feedback High satisfaction when monitoring and counselling are provided.

Anecdotes are useful but clinical monitoring remains essential.

Access & Purchase Options

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Methotrexate is prescription‑only and commonly dispensed through major community pharmacy chains across Australia.

Hospital pharmacies dispense injectable formulations and high‑dose oncology preparations.

Online Pharmacies And Telehealth E‑Prescriptions

Accredited online pharmacies and telehealth services can arrange e‑prescriptions and home delivery for many patients.

In our online pharmacy, rheumatrex is available without a prescription, with discreet delivery to Australia in 9‑21 days.

  • Steps to get supply: obtain GP or specialist script (include PBS authority if required).
  • Check PBS eligibility and concession status before filling the script.
  • Arrange pharmacist counselling for injectables and device training when needed.
Source Type Pros Cons Typical Wait Time PBS Subsidy
Community Pharmacy (chains) Local counselling, quick supply for tablets. Injectables may need hospital sourcing. Same day–3 days Yes for approved indications
Hospital Pharmacy Handles injectables and oncology dosing. Not for routine community dispensing. Varies Yes for inpatient/outsourced programs
Accredited Online Pharmacy Convenience and home delivery. Prescription required; check accreditation. 2–14 days May apply

Avoid importing methotrexate without a prescription and confirm TGA importation rules and emergency supply procedures with your pharmacist.

Mechanism & Pharmacology

Simplified Explanation

Methotrexate is an antimetabolite and folic acid analogue that inhibits dihydrofolate reductase and related enzymes.

That inhibition reduces DNA synthesis and modifies immune responses, which explains both antineoplastic and immunomodulatory effects.

Clinical Terms

Low weekly doses act primarily by immune modulation and are used as a DMARD in rheumatology and dermatology.

High oncology doses are cytotoxic and require specialist protocols and folinic acid (leucovorin) rescue.

Antimetabolite
A drug that interferes with cellular metabolism needed for DNA synthesis.
Folinic Acid Rescue
Leucovorin given after high‑dose methotrexate to reduce toxicity.
Bioavailability
Proportion of drug reaching systemic circulation; oral absorption can be less at higher doses.
Subcutaneous Versus Oral
Injectable routes bypass gut absorption and can provide more predictable exposure at higher doses.
Use Effect Monitoring / Rescue
Low‑dose Rheumatology Immunomodulation CBC, LFTs, creatinine; folic acid
High‑dose Oncology Cytotoxic Intensive monitoring; leucovorin rescue

Oral and injectable forms are not interchangeable mg:mg without prescriber approval.

Indications & Off‑Label Uses

Approved Indications By TGA

TGA brand‑by‑brand labelling should be checked for exact indications.

Commonly used, approved indications internationally include rheumatoid arthritis, juvenile idiopathic arthritis, severe psoriasis and certain oncology uses.

Off‑Label Uses In Australian Clinical Practice

Specialists sometimes prescribe methotrexate off‑label for certain dermatological or rheumatological conditions where evidence supports benefit.

Indication Typical Dose Range PBS Subsidy Status
Rheumatoid Arthritis 7.5–15 mg weekly Commonly PBS‑listed
Severe Psoriasis 10–25 mg weekly May be PBS‑listed for approved cases
Juvenile Idiopathic Arthritis 10–15 mg/m² weekly Specialist prescriptions
  • Off‑label decision factors: evidence base, specialist oversight, informed consent, effective contraception counselling.
  • Document informed consent and counsel thoroughly about teratogenic risks in people of childbearing potential.

Oncology dosing differs markedly and must be managed in hospital settings.

Key Clinical Findings

Methotrexate shows symptom improvement in rheumatoid arthritis within 3–6 weeks with full benefit often by 12 weeks.

Randomised trials and registries support better tolerability and efficacy when folic acid is co‑prescribed.

Studies comparing oral versus subcutaneous routes show improved bioavailability and responses with injectable methotrexate at higher doses.

Meta‑analyses report hepatotoxicity as a manageable risk with routine monitoring and alcohol avoidance.

  • Top studies to reference: major rheumatology trials and long‑term registry cohorts showing sustained disease control and safety with monitoring.
  • Evidence supports combination DMARD strategies in specialist care to achieve remission.
  • Gaps remain around optimal monitoring intervals for certain comorbid populations.

Follow Australian guidelines such as those from the Royal Australian College of General Practitioners and specialist rheumatology societies for detailed recommendations.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Mechanism Place In Sequence Monitoring Needs PBS Restrictions
Leflunomide Pyrimidine synthesis inhibitor Second‑line or alternative to methotrexate LFTs, CBC Authority may apply
Sulfasalazine Anti‑inflammatory; unclear exact mechanism First/second line in some regimens CBC, LFTs Generally PBS‑listed
Hydroxychloroquine Immunomodulator Often used in combination Ocular screening PBS listed for certain indications
Biologics (e.g., Adalimumab) Targeted cytokine inhibitors Step‑up after DMARD failure Infection screening, more intensive monitoring Strict PBS criteria and higher cost

Pros And Cons Checklist

  • Consider comorbidities, childbearing plans, liver disease, infection risk and PBS cost when choosing alternatives.
  • Methotrexate remains a cornerstone DMARD; biologics are usually considered when methotrexate is insufficient or contraindicated.
  • Non‑pharmacological adjuncts: physiotherapy, weight management and optimised vaccination status.

Common Questions

Patients frequently ask about contraception, pregnancy timing and breastfeeding safety.

Answer: do not conceive while taking methotrexate and continue reliable contraception during treatment and for a prescriber‑advised interval afterwards.

Breastfeeding is contraindicated while using methotrexate at therapeutic doses.

Alcohol should be minimised due to liver risk.

Bring a current medication list to pharmacy consultations including supplements and herbal products.

Contact Poisons Information on 13 11 26 in case of suspected overdose or severe reaction.

  • Missed dose: follow the weekly skip guidance; never double dose.
  • Vaccination: avoid live vaccines while immunosuppressed; inactivated vaccines are generally safe but check timing.
  • Fertility: discuss with your specialist if planning pregnancy; both partners may need counselling.
  • Monitoring frequency: CBC, LFTs and creatinine every 1–3 months as standard.
  • Injection technique: request pharmacist or nurse training for self‑administration of prefilled injectors.

Provide patients with a printable checklist for appointments including baseline labs and contraception confirmation to improve safety.

Price & Access Comparison Table

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Typical Price Range PBS Subsidy Prescription Required Expected Wait Time
Community Pharmacy Varies; usually low out‑of‑pocket with PBS Yes for approved indications Yes Same day–3 days
Hospital Pharmacy Typically covered in inpatient setting Yes Yes Varies
Online Pharmacy Varies; check accreditation and delivery fees May apply Yes 2–14 days

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Confirm PBS concession card and eligibility to reduce cost.
  • Ask pharmacist about generic substitution and brand availability.
  • Plan repeats and secure home delivery if rural to avoid stockouts.
  • Consider bulk supplies where clinically appropriate and allowed by prescription rules.

Registration & Regulation

TGA Approval

The Therapeutic Goods Administration approves specific methotrexate formulations for supply in Australia and maintains ARTG entries.

Check ARTG entries for each brand and strength when preparing product information.

PBS Subsidy Details

The PBS commonly subsidises low‑dose methotrexate for approved rheumatology and dermatology indications.

Certain strengths or indications may require an Authority prescription to access subsidy.

ARTG
Australian Register of Therapeutic Goods identifier for a registered medicine.
PBS
Pharmaceutical Benefits Scheme that subsidises medicines for eligible patients.
Authority Script
A prescription requiring approval for PBS subsidy based on indication criteria.

Report adverse events through the TGA adverse event reporting portal and follow mandatory pharmacovigilance procedures.

Storage & Handling

Household Storage In Australian Climate (Heat/Humidity)

Store tablets and solutions at 15–25°C and keep away from moisture and direct light.

Avoid leaving methotrexate in a hot car glovebox during Australian summers.

Keep all methotrexate products secure and out of reach of children and pets.

Cold‑Chain Handling For Pharmacies

Some injectable presentations require controlled transport and insulated packaging to avoid heat exposure.

Pharmacies should follow manufacturer and cold‑chain guidance for storage and dispatch of prefilled injectors and vials.

Formulation Storage Tips
Tablets Room temperature 15–25°C; dry place.
Oral Solution 15–25°C; keep capped and protected from light.
Prefilled Syringe Store per manufacturer; avoid heat; insulated delivery advised in hot weather.
Injection Vial Follow vial labelling and cold‑chain if specified.
  • Return unused cytotoxic medicines to the pharmacy for safe disposal.
  • Use insulated packaging for injectables when transporting long distances in summer.

Guidelines For Proper Use

Australian Pharmacist Counselling Style

Confirm the indication and explain the once‑weekly dosing clearly and which day of the week to take it.

Reinforce that methotrexate is teratogenic and document negative pregnancy testing and contraception counselling where applicable.

Review alcohol intake and record all medications and supplements including herbal products.

Patient Advice From PBS And National Health Authorities

Set a monitoring timetable: CBC, LFTs and creatinine every 1–3 months as standard during maintenance therapy.

Provide a patient handout checklist covering baseline tests, folic acid dosing, vaccination status and red‑flag symptoms such as fever, sore throat, mouth ulcers or jaundice.

  • Counselling script bullets for pharmacists: confirm weekly dose, advise folic acid, arrange baseline and ongoing blood tests, show injectable device and sharps disposal options.
  • Document counselling and refer promptly to rheumatologist for unusual results or side effects.

Link patients to PBS consumer medicine information and TGA resources for up‑to‑date safety advice.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9–14 days
Melbourne Victoria 9–14 days
Brisbane Queensland 9–14 days
Perth Western Australia 9–14 days
Adelaide South Australia 9–14 days
Hobart Tasmania 9–14 days
Darwin Northern Territory 9–14 days
Canberra Australian Capital Territory 9–14 days
Gold Coast Queensland 9–14 days
Newcastle New South Wales 9–14 days
Wollongong New South Wales 14–21 days
Sunshine Coast Queensland 14–21 days
Geelong Victoria 14–21 days
Townsville Queensland 14–21 days

Related products